Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00737789
What this trial is testing

Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Ferring Pharmaceuticals 206
Large-scale testing (Phase 3)Study completedNCT01172938
What this trial is testing

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 504
Not applicableStudy completedNCT02554474
What this trial is testing

OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis

Who this might be right for
Joint DiseasesRheumatoid ArthritisSystemic Lupus Erythematosus
University of British Columbia 118
Large-scale testing (Phase 3)Ended earlyNCT00206713
What this trial is testing

Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 264
Not applicableStudy completedNCT03089151
What this trial is testing

Denver Garden Environment and Microbiome Study Disease

Who this might be right for
Diet ModificationPhysical ActivityWeight Gain+3 more
University of Colorado, Boulder 16
Testing effectiveness (Phase 2)WithdrawnNCT01658605
What this trial is testing

Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline
Testing effectiveness (Phase 2)UnknownNCT02442037
What this trial is testing

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT01576120
What this trial is testing

Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients

Who this might be right for
Crohn's Disease
Medtronic - MITG 40
Testing effectiveness (Phase 2)Study completedNCT05377580
What this trial is testing

Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Innovent Biologics (Suzhou) Co. Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT05013905
What this trial is testing

A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)

Who this might be right for
Crohn Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 55
Early research (Phase 1)Study completedNCT02818686
What this trial is testing

TD-1473 for Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Theravance Biopharma 40
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Not applicableUnknownNCT03012542
What this trial is testing

Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease

Who this might be right for
Crohn Disease
University of Washington 32
Early research (Phase 1)Study completedNCT06070571
What this trial is testing

Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group

Who this might be right for
Gingivitis
Deraya University 40
Early research (Phase 1)Study completedNCT00007163
What this trial is testing

Monoclonal Antibody Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)Study completedNCT01863732
What this trial is testing

Extension in AS: Sustainability of Benefits, Safety and Tolerability

Who this might be right for
Spondylitis, Ankylosing
Novartis Pharmaceuticals 274
Not applicableUnknownNCT06460766
What this trial is testing

Validity and Reliability of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Questionnaire

Who this might be right for
Rheumatic DiseasesPediatric ALLChildren, Only
Istanbul University - Cerrahpasa 70
Post-approval studies (Phase 4)Ended earlyNCT01802593
What this trial is testing

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

Who this might be right for
Crohn's Disease
Prof. Arie Levine 20
Large-scale testing (Phase 3)Study completedNCT02708771
What this trial is testing

Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity

Who this might be right for
Heart Failure
Hospital San Juan de la Cruz 42
Not applicableUnknownNCT02972398
What this trial is testing

N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

Who this might be right for
Major Depressive Disorders
Tianjin Anding Hospital 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation